day 1 agenda

Mon , Jun 10, 2019

  • 08:00
  • Registrations

  • 08:45
  • Opening Ceremony & Welcome Speech

  • 09:00
  • Keynote Talk-1 : 3D Printed Corneal Equivalent

    Sachdeva Mandip S, Florida A&M University, USA

  • 09:30
  • Keynote Talk-2 : Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.

    Kaliappanadar Nellaiappan, Curirx inc, USA

  • 10:00
  • Keynote talk-3 : Preparation and nanoformulation of new quinolone scaffold-based anticancer agents: Enhancing solubility for better cellular delivery

    Reem K. Arafa, Zewail City of Science and Technology, Egypt

  • 10:30
  • Keynote Talk-4: Lung Delivery of Biopharmaceuticals using Nanocarrier Systems

    Imran Saleem, Liverpool John Moores University, UK

  • 11:00
  • Refreshment Break @ Foyer

  • 11:20
  • Scientific Session : High gene delivery efficiency mediated by lipid- and polymer-based nanosystems

    Henrique Faneca, University of Coimbra, Portugal

  • 11:40
  • Scientific Session : Targeting c-MYC and c-MYC regulating microRNAs in ovarian cancer with liposomal-interference RNA

    Pablo Vivas-Mejia, University of Puerto Rico, Puerto Rico

  • 12:00
  • Scientific Session : Cell-based chemoresistance models to evaluate combinational nanoformuations

     Badiree Konkimalla, National Institute of Science Education and Research (NISER), India

  • 12:20
  • Scientific Session : Inorganic Nanomaterials as Carriers in Targeted Delivery of Anticancer Drugs

    R.M.G. Rajapakse, University of Peradeniya, Sri Lanka

  • 12:40
  • Scientific Session : Nanoparticle Engineering towards Highly Efficient Drug Delivery Systems and SERS-based Bio-Sensing

    Beatrice Fortuni, KU Leuven, Belgium

  • 13:00
  • Lunch @ Restarunt

  • 13:50
  • Scientific Session : The Importance of Modernization of Acetaminophen (Paracetamol) containing Documentary Standards to Global Public Health

    Clydewyn Anthony, United States Pharmacopeial Convention, USA

  • 14:10
  • Scientific Session : Marine Compound Xyloketal B as a Novel Drug Candidate for Cardiovascular and neuronal protection

    Guan-Lei Wang, Sun Yat-sen University, China

  • 14:30
  • Scientific Session : Amino acid based surfactants: A class of amphiphiles with potential applications in the pharmaceutical field

    Diego Romano Perinelli, University of Camerino, Italy

  • 14:50
  • Scientific Session : Development and Pharmacokinetic Evaluations of a Co-Solvent and a PLGA-based Nanospheres of Itraconazole for Intravenous Administrations

    Dong Liang, Texas Southern University, USA

  • 15:10
  • Scientific Session : Subcutaneous formulation of furosemide: endless opportunities for an old drug

    Tamas Alexy, University of Minnesota, USA

  • 15:30
  • Scientific Session : Treatment of animal model for hot flushes by nasal administration of a non-hormonal drug delivery system

    Hiba Natsheh, Hebrew University of Jerusalem, Israel

  • 15:50
  • Coffee Break @ Foyer

  • 16:10
  • Special Session: Phytochemical compounds of Selected Lebanese Plants with Potential Biological activities

    Maha Aboul-Ela, Faculty of Pharmacy, Beirut Arab University, Lebanon

  • 16:30
  • Special Session: Contribution of Developed Prototype Research Software Relevant to Infants’ Prakriti (Physical constitution) Assessment for Vikriti (Pathological condition) Management and Possible Future Disorders

    Srivastava Niraj, Government Ayurvedic PG College, India

  • 16:50
  • Special Session : Role of Leech Therapy in Different Diseases W.S.R. Deep vein Thrombosis (DVT)

    Varsha Saxena, Uttarakhand Ayurveda University (UAU), India

day 2 agenda

Tue , Jun 11, 2019

  • 08:30
  • Registrations

  • 09:00
  • Keynote Talk-1 : Bridging Discovery program to Development-The Making of a Phase I Trial Study

    Elizabeth Kwong, Kwong Eureka Solutions, Canada

  • 09:40
  • Keynote talk-2 : Material properties impacting micronization behavior of a crystalline drug

    Ajit Narang, Genentech Inc., USA

  • 10:10
  • Keynote talk-3 : Development of a novel anti-Ran-GTPase peptide nanoparticles as a novel approach for antimetastatic therapies

    Ahmed Faheem, University of Sunderland, UK

  • 10:40
  • Keynote talk-4 : Development of integrated enzymatic electrophoretic methodologies for the quality control of therapeutic biomolecules

    Catherine Perrin, University of Montpellier, France

  • 11:10
  • Coffee Break @ Foyer

  • 11:30
  • Scientific Session : Biorelevant Dissolution to Facilitate Formulation Development of a BSC Class 2 Basic Compound and Overcome Drug-Drug Interaction with Acid Reducing Agents

    Dawen Kou, Genentech, USA

  • 11:50
  • Scientific Session : Our smeared FE computational models for drug delivery in organs and tumors

    Milos Kojic, Serbian Academy of Sciences and Arts, Serbia

  • 12:10
  • Scientific Session : Divorce uses of gabapentenoids and it’s implications- a new public health issue

    Shubhakaran Khichar, Dr. S. N. Medical College, India

  • 12:30
  • Scientific Session : Chiral HPLC Resolution of a Potentially Serious Global Health Crisis

    Clydewyn Anthony, United States Pharmacopeial Convention, USA

  • 12:50
  • Scientific Session : Patient Registries and the EU Regulatory Framework: Some Reflections

    Charlotte Ryckman, Covington & Burling LLP

  • 13:20
  • Lunch @ Restaurant

  • 14:10
  • Scientific Session : Precision Medicine Collaborations at the Industry- Academic Interface

    Patrick J Silva, University of Arizona Health Sciences, USA

  • 14:20
  • Scientific Session : A Pharmacokinetic Study of Medazolam and Ketamine in Patients on Extracorporeal Membrane Oxygenation Therapy

    Gagan Kaushal, Thomas Jefferson University, USA

  • 14:50
  • Scientific Session : Analysis 3-Hydroxypropyl Mercapturic Acid (3- HPMA) in Urine of Breast Cancer Patient for Monitoring the Toxicity of Cyclophosphamide

    Yahdiana Harahap, Universitas Indonesia, Indonesia

  • 15:10
  • Scientific Session : Bactericidal autophagy inhibitors in cancer treatment

    Benedetto Grimaldi, Italian Institute of Technology, Italy

  • 15:30
  • Scientific Session : In vitro lung epithelial cell transport and antiinterleukin- 8 releasing activity of liposomal ciprofloxacin

    Ruba S. Darweesh, Jordan University of Science and Technology, Jordan

  • 15:50
  • Scientific Session : Spiro-fused cyclopropa[a]pyrrolizines and 3-azabicyclo[3.1.0]hexanes as potential antitumor agents

    Vitali M Boitsov, Saint Petersburg Academic Universitry, Russia

  • 16:10
  • Scientific Session : 3D Bioprinting Substitute Encapsulated with Cells and Growth Factor

    Lei Nie, KU Leuven, Belgium

  • 16:30
  • Coffee Break @ Foyer

day 3 agenda

Wed , Jun 12, 2019

  • 10:00
  • Networking

  • 12:30
  • Lunch @ Restaurant 

Scientific Program Download